
Tranesma 500mg Tablet SR
Marketer
Akumentis Healthcare Ltd
Salt Composition
Tranexamic Acid (500mg)
Overview Tranesma 500mg Tablet SR
Tranesma 500mg sustained-release tablets control hemorrhaging. They are beneficial in preventing or lessening blood loss associated with dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and procedures involving the mouth, prostate, or bladder. This anti-fibrinolytic medication functions by inhibiting clot dissolution, thus halting bleeding. Dosage and treatment duration must adhere strictly to your physician's instructions. Avoid use if allergic to this medication. Fatigue and musculoskeletal pain are frequently reported. Disclose any history of cardiac surgery or kidney impairment to your doctor. This medication is considered safe for use during pregnancy and breastfeeding, and in individuals with liver disease. Alcohol consumption following administration should be avoided due to the potential for increased somnolence.
Primary Ingredients of Tranesma 500mg Tablet SR
No information provided. Therefore, no text can be rewritten.
Uses of Tranesma 500mg Tablet SR
Managing Hemorrhage
Major Benefits of Tranesma 500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg Tranesma SR tablet whole; do not break, crush, or chew it. Take with food.
Common Side effects of Tranesma 500mg Tablet SR:
- Musculoskeletal (bone, muscle or joint) pain
- Joint pain
- Headache
- Back pain
- Vomiting
- Nausea
- Abdominal pain
- Fatigue
- Diarrhea
- Hypotension (low blood pressure)
- Sinus disorder
- Anemia (low number of red blood cells)
- Allergic dermatitis
- Lightheadedness
- Thromboembolism
How to use Tranesma 500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg Tranesma SR tablet whole; avoid crushing, chewing, or breaking it. Take it with a meal.
How Tranesma 500mg Tablet SR works:
Hemostatic agent Tranesma 500mg sustained-release tablets inhibit fibrinolysis, thereby stabilizing blood clots and mitigating excessive hemorrhage associated with menstruation or post-surgical procedures.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tranesma 500mg sustained-release tablets and alcohol can lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Tranesma 500mg sustained-release tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingSAFE IF PRESCRIBED
Prolonged-release Tranesma 500mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Tranesma 500mg sustained-release tablets.
KidneyCAUTION
Patients with impaired kidney function should use Tranesma 500mg sustained-release tablets cautiously. Dosage modification of Tranesma 500mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tranesma 500mg Tablet SR in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Tranesma 500mg Tablet SR :
Omit the missed Tranesma 500mg Tablet SR dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Tranesma 500mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
